Nomura Asset Management
IONS icon

Nomura Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Nomura Asset Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7,417
Closed -$279K – 997
2021
Q2 		$296K Sell
7,417
-15,883
-68% -$622K ﹤0.01% 941
2021
Q1 		$1.05M Buy
23,300
+500
+2% +$27.9K 0.01% 827
2020
Q4 		$1.29M Buy
22,800
+200
+0.9% +$9.97K 0.01% 789
2020
Q3 		$1.07M Hold
22,600
– – 0.01% 767
2020
Q2 		$1.33M Hold
22,600
– – 0.01% 705
2020
Q1 		$1.07M Buy
22,600
+2,600
+13% +$145K 0.01% 680
2019
Q4 		$1.21M Hold
20,000
– – 0.01% 752
2019
Q3 		$1.2M Hold
20,000
– – 0.01% 737
2019
Q2 		$1.28M Buy
+20,000
New +$1.41M 0.01% 716
2016
Q3 		– Sell
-13,420
Closed -$313K – 998
2016
Q2 		$313K Hold
13,420
– – 0.01% 836
2016
Q1 		$544K Buy
13,420
+1,200
+10% +$48.7K 0.01% 782
2015
Q4 		$757K Hold
12,220
– – 0.01% 700
2015
Q3 		$494K Sell
12,220
-9,000
-42% -$466K 0.01% 794
2015
Q2 		$1.22M Sell
21,220
-5,000
-19% -$318K 0.02% 536
2015
Q1 		$1.67M Buy
26,220
+8,720
+50% +$592K 0.03% 442
2014
Q4 		$1.08M Hold
17,500
– – 0.02% 575
2014
Q3 		$680K Buy
17,500
+2,500
+17% +$88.6K 0.01% 697
2014
Q2 		$517K Hold
15,000
– – 0.01% 758
2014
Q1 		$648K Hold
15,000
– – 0.01% 715
2013
Q4 		$598K Sell
15,000
-5,000
-25% -$178K 0.01% 726
2013
Q3 		$751K Sell
20,000
-5,000
-20% -$149K 0.01% 644
2013
Q2 		$672K Buy
+25,000
New +$532K 0.01% 652

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nomura Asset Management's IONS Position: Q3 2021 in Review

Nomura Asset Management sold out of Ionis Pharmaceuticals (IONS) in Q3 2021, closing a stake of 7,417 shares — an estimated $279K sold.

Nomura Asset Management first reported a position in IONS in Q2 2013 and held it in 22 quarters. The position peaked at $1.67M in Q1 2015. 324 funds tracked by Wall St. Rank hold IONS as of Q3 2021.

  • Nomura Asset Management reported no remaining Ionis Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Nomura Asset Management sold 7,417 Ionis Pharmaceuticals shares in Q3 2021, an estimated $279K.
  • Nomura Asset Management first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 22 quarters.
  • Nomura Asset Management's Ionis Pharmaceuticals position peaked at $1.67M in Q1 2015.
  • 324 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2021.

Based on Nomura Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.